Statins for the primary prevention of cardiovascular disease-Reference-Cited by-同舟云学术

Statins for the primary prevention of cardiovascular disease

Published:2013-01-31 Issue:9 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Taylor Fiona¹,Huffman Mark D²,Macedo Ana Filipa³,Moore Theresa HM⁴,Burke Margaret⁵,Davey Smith George⁶,Ward Kirsten⁷,Ebrahim Shah¹,Gay Hawkins C⁸

Affiliation:

1. Department of Non-communicable Disease Epidemiology; London School of Hygiene & Tropical Medicine; London UK

2. Departments of Preventive Medicine and Medicine (Cardiology); Northwestern University Feinberg School of Medicine; Chicago IL USA

3. Faculty of Health Sciences; University of Beira Interior; Covilha Portugal

4. Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK

5. Department of Social Medicine; University of Bristol; Bristol UK

6. MRC Integrative Epidemiology Unit, School of Social and Community Medicine; University of Bristol; Bristol UK

7. Department of Twin Research & Genetic Epidemiology; King's College London; London UK

8. Northwestern University; Chicago USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004816.pub5/fullpdf

Reference293 articles.

1. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study);Cui;American Journal of Cardiology,2009

2. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group;Furberg;Circulation,1994

3. Effect of Lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: A post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study;Kendrick;American Journal of Kidney Diseases,2009

4. Splichal JE Ornstein DL Hong-Dice YG Downs JR Fischer JR Lovastatin for the prevention of Melanoma: Analysis of AFCAPS/TexCaps Proceedings of the American Society of Clinical Oncology 2001

5. Brookes L Nakamura H MEGA: Management of elevated cholesterol in the primary prevention group of adult Japanese American Heart Association 2005 Scientific Sessions 2008

Cited by 1101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Statin Landscape: A Comprehensive Review of Stroke Prevention Strategies;Cureus;2024-02-04

2. Optimization and modelling of pravastatin recovery from aqueous solutions using reactive extraction methodology;The Canadian Journal of Chemical Engineering;2024-01-30

3. In-Vitro Effect of Statins on Enterococcus Faecalis;Journal of Dental Health and Oral Research;2024-01-29

4. Should major trauma fractures be part of a fracture liaison service’s remit: A cost benefit estimate;2024-01-10

5. Statin therapy in individuals with intermediate cardiovascular risk;Metabolism;2024-01